estrone has been researched along with medroxyprogesterone acetate in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (18.03) | 18.7374 |
1990's | 29 (47.54) | 18.2507 |
2000's | 16 (26.23) | 29.6817 |
2010's | 5 (8.20) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Jensen, HK; Pedersen, OD | 1 |
Caplan, RH; Hodgson, SF; Judd, HL; Kotowicz, MA; Lane, AW; Lufkin, EG; O'Fallon, WM; Riggs, BL; Wahner, HW | 1 |
Bellantoni, MF; Blackman, MR; Cho, DE; Harman, SM | 1 |
Bellantoni, MF; Blackman, MR; Cullins, VE; Engelhardt, SM; Harman, SM | 1 |
Sherwin, BB | 1 |
Cedars, MI; Judd, HL; Lu, JK; Meldrum, DR | 1 |
Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
Lundgren, S; Lønning, PE | 1 |
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Purohit, A; Reed, MJ; Singh, A | 1 |
Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE | 1 |
Lobo, RA; Montz, FJ; Shoupe, D | 1 |
Alapin-Rubillovitz, S; Casper, RF | 1 |
Adlercreutz, H; Hämäläinen, EK; Korpela, JT; Pulkkinen, MO | 1 |
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
Lobo, RA; McCormick, W; Roy, S; Singer, F | 1 |
Evans, CA; Kennedy, TG | 1 |
Liu, HC; Tseng, L | 1 |
Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM | 1 |
Aono, T; Hata, K; Irahara, M; Sunahara, S; Uemura, H; Yasui, T; Yoneda, N | 1 |
Geng, CS; Labrie, F; Lévesque, C; Li, S; Yan, X | 1 |
Nand, SL; Webster, MA; Wren, BG | 1 |
Leung, B; Lobo, R; Mezrow, G; Pike, M; Shoupe, D; Spicer, D | 1 |
Johnson, SH; Olsson, SE; Svensson, LO | 1 |
Castiglioni, E; Farina, M; Gabrielli, L; Nencioni, T; Penotti, M; Polvani, F | 1 |
Couture, P; Labrie, F; Simard, J; Thériault, C | 1 |
Dowsett, M; Edmonds, DK; Howell, R; King, N | 1 |
Collins, WP; Jaggers, DC; Milligan, SR | 1 |
Barbieri, RL; Gao, X; Ginsburg, ES; Mello, NK; Mendelson, JH; Rothman, M; Sholar, JW; Teoh, SK | 1 |
AinMelk, Y | 1 |
Affandi, B; Belsey, EM; d'Arcangues, C; Dusitsin, N; Hadisaputra, W; Kazi, A; Kirwat, O; Koetsawang, S; Noonan, E; Olayinka, I; Pinol, A; Piya-Anant, M; Ramos, RM; Rocca, M; Sadek, W; Said, S; Sethavanich, S | 1 |
Doyle, MC; Feely, J; Harrison, RF; Wen, Y | 1 |
Labrie, C; Labrie, F; Luo, S; Stojanovic, M | 1 |
Hall, G; Landgren, BM; Pripp, U; Schenck-Gustafsson, K | 1 |
Baber, R; Nand, SL; O'Connor, V; Webster, MA | 1 |
Adams, MR; Schwenke, DC; Wagner, JD | 1 |
Gross, BA; Heller, GZ; Nand, SL; Wren, BG | 1 |
Arcuri, F; Carducci, A; Cintorino, M; Paulesu, L; Ricci, C; Runci, Y; Sestini, S | 1 |
Honjo, H; Iwasa, K; Kikuchi, N; Okubo, T; Tsuchiya, H; Urabe, M; Yamamoto, T; Yokota, K | 1 |
Luciano, AA; Miller, BE; Schaser, RJ; Schoenenfeld, MJ | 1 |
Fukaya, T; Ikenoue, N; Okatani, Y; Wakatsuki, A | 1 |
Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T | 1 |
Benencia, H; Gutierrez, P; Mesch, V; Novelli, JA; Siseles, NO | 1 |
Baber, R; Heller, GZ; Nand, SL; Webster, MA | 1 |
Hyde, BM; Wilborn, WH | 1 |
Fukaya, T; Okatani, Y; Wakatsuki, A | 1 |
Alvarez-Vasquez, RB; Axelrod, D; Bradlow, HL; Frenkel, K; Newman, MC; Sepkovic, DW; Zumoff, B | 1 |
Edwards, JP; Jones, TK; Mais, DE; Marschke, KB; Motamedi, M; Pio, B; Risek, B; Schrader, WT; Tegley, CM; Zhi, L | 1 |
BARNES, LE; MEYER, RK | 1 |
Bhagat, CI; Criddle, RA; Dhaliwal, SS; Drury, PJ; Faulkner, DL; Gutteridge, DH; Holzherr, ML; Jamrozik, K; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Tran, L; Will, RK | 1 |
Furumoto, H; Irahara, M; Kuwahara, A; Maegawa, M; Matsuzaki, T; Miura, M; Saito, S; Takikawa, M; Uemura, H; Umino, Y; Yasui, T | 2 |
Greendale, GA; Palla, SL; Pike, MC; Reboussin, BA; Slone, S; Ursin, G; Wasilauskas, C | 1 |
Barrett-Connor, E; Crandall, C; Greendale, GA; Herrington, DM; Hu, P; Palla, SL; Reboussin, BA; Reuben, DB | 1 |
Greenberg, DL; Krishnan, RR; MacFall, JR; Payne, ME; Provenzale, JM; Steffens, DC | 1 |
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA | 1 |
Kaplan, PF; Meendering, JR; Minson, CT; Torgrimson, BN | 1 |
28 trial(s) available for estrone and medroxyprogesterone acetate
Article | Year |
---|---|
Treatment of postmenopausal osteoporosis with transdermal estrogen.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Bone Density; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Spinal Fractures | 1992 |
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; Body Weight; Delayed-Action Preparations; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Placebos; Vagina | 1991 |
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Sexual Behavior; Testosterone | 1991 |
Adrenal steroids as parameters of the bioavailability of MA and MPA.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1990 |
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin | 1990 |
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Topics: Adult; Contraceptive Agents, Female; Erythromycin; Estradiol; Estrone; Ethinyl Estradiol; Feces; Female; Humans; Intestines; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Oxytetracycline; Trimethoprim | 1984 |
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol | 1995 |
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
Topics: Administration, Oral; Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1995 |
Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
Topics: Adult; Bone Density; Delayed-Action Preparations; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Leuprolide; Medroxyprogesterone Acetate; Premenstrual Syndrome; Prospective Studies | 1994 |
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Reference Values; Single-Blind Method | 1994 |
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Estradiol; Estrogen Replacement Therapy; Estrone; Feedback; Female; Follicle Stimulating Hormone; Goserelin; Humans; Inhibins; Luteinizing Hormone; Medroxyprogesterone Acetate; Prospective Studies | 1995 |
Effects of alcohol ingestion on estrogens in postmenopausal women.
Topics: Alcohol Drinking; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Ethanol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause | 1996 |
Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
Topics: Blood Pressure; Drug Combinations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Hemorrhage | 1996 |
Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Developmen
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1996 |
Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.
Topics: Aged; Angina Pectoris; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Middle Aged; Patient Compliance; Postmenopause; Progesterone Congeners; Quality of Life; Safety; Time Factors | 1998 |
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Topics: Adult; Biopsy, Needle; Double-Blind Method; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Uterine Hemorrhage | 1998 |
Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
Topics: Adult; Bone Density; Double-Blind Method; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners | 1999 |
Effects of estrone sulfate alone or with medroxyprogesterone acetate on serum lipoprotein levels in postmenopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Combinations; Estrone; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Triglycerides | 2001 |
Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
Topics: Blood Flow Velocity; Blood Pressure; Brachial Artery; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Antagonism; Endothelium, Vascular; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Heart Rate; Humans; Japan; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Postmenopause; Ultrasonography; Vascular Patency; Vasodilation; Vasodilator Agents | 2001 |
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
Topics: Adult; Animals; Bone Density; Bone Remodeling; CA-125 Antigen; Endometriosis; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Gonadotropin-Releasing Hormone; Horses; Humans; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Hemorrhage | 2001 |
Once and twice a week transdermal estradiol delivery systems: clinical efficacy and plasma estrogen levels.
Topics: Administration, Cutaneous; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Protein Binding; Sex Hormone-Binding Globulin | 1998 |
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Female; Headache; Humans; Libido; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nausea; Pain; Vaginal Diseases; Vasomotor System | 1998 |
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Calcitriol; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Hip Joint; Humans; Hydroxyproline; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Quality of Life; Severity of Illness Index; Single-Blind Method; Spinal Fractures; Treatment Outcome | 2003 |
Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
Topics: Adult; Aged; Bone Density; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Radioimmunoassay; Spine | 2004 |
Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Topics: Breast; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Predictive Value of Tests; Progesterone; Progesterone Congeners; Randomized Controlled Trials as Topic | 2004 |
Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Topics: Administration, Oral; Body Mass Index; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Postmenopause | 2005 |
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Topics: Aged; Estradiol; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tissue Distribution; Uterine Prolapse; Vagina | 2007 |
33 other study(ies) available for estrone and medroxyprogesterone acetate
Article | Year |
---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
Topics: Administration, Cutaneous; Administration, Oral; Climacteric; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Lipids; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Sex Hormone-Binding Globulin | 1992 |
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Pelvic Neoplasms | 1990 |
The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours.
Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Tumor Cells, Cultured | 1989 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone | 1987 |
The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
Topics: Adult; beta-Endorphin; Castration; Endorphins; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Follicular Phase; Humans; Luteal Phase; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Naloxone; Progestins; Prolactin | 1985 |
Progestins increase endogenous opioid peptide activity in postmenopausal women.
Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Progestins; Prolactin | 1985 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hydroxyproline; Immunosuppressive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Random Allocation | 1984 |
Blastocyst implantation in ovariectomized, adrenalectomized hamsters treated with inhibitors of steroidogenesis during the pre-implantation period.
Topics: Adrenalectomy; Aminoglutethimide; Animals; Blastocyst; Castration; Cricetinae; Cyanoketone; Embryo Implantation; Embryonic Development; Estradiol; Estrone; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesocricetus; Ovary; Pregnancy; Progesterone; Prostaglandins; Uterus | 1980 |
Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro.
Topics: Arylsulfotransferase; Cells, Cultured; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Phenols; Phosphoadenosine Phosphosulfate; Progesterone; Sulfurtransferases | 1981 |
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Radioimmunoassay; Uterine Hemorrhage | 1995 |
Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Uterus | 1995 |
Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Carotid Artery, Internal; Cerebral Arteries; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pulsatile Flow; Regional Blood Flow; Ultrasonography | 1993 |
Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Dexamethasone; Dihydrotestosterone; Estradiol; Estrone; Flutamide; Humans; Kinetics; Medroxyprogesterone Acetate; Receptors, Androgen; Tumor Cells, Cultured | 1993 |
Potent inhibitory effects of steroids in an in vitro model of angiogenesis.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Aorta; Cortodoxone; Culture Techniques; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Hydrocortisone; Medroxyprogesterone Acetate; Models, Biological; Neovascularization, Physiologic; Progesterone; Rats; Rats, Wistar | 1996 |
The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
Topics: Antioxidants; Arteriosclerosis; Cell Membrane; Chromatography, High Pressure Liquid; Contraceptives, Oral; Erythrocytes; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follow-Up Studies; Humans; Incidence; Lipids; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Vitamin E | 1997 |
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Carcinogens; Cell Division; Drug Screening Assays, Antitumor; Estrogen Antagonists; Estrone; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Organ Size; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus; Vagina | 1997 |
In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
Topics: Alkenes; alpha-Tocopherol; Amidines; Animals; Cholesterol, HDL; Copper; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; gamma-Tocopherol; Lipid Peroxidation; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Molecular Weight; Multivariate Analysis; Tamoxifen | 1999 |
Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Breast Neoplasms; Carcinoma; Corticosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Mifepristone; NAD; Progesterone Congeners; Progestins; RNA, Messenger; Tumor Cells, Cultured | 2000 |
Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells.
Topics: Arteriosclerosis; Blotting, Southern; Cells, Cultured; Drug Interactions; Estrone; Gene Expression Regulation, Developmental; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Muscle Development; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2000 |
Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Endometrium; Estrogens; Estrone; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Medroxyprogesterone Acetate; Menopause; Physiology; Reproduction; Reproductive Control Agents; Therapeutics; Urogenital System; Uterus | 1983 |
Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Topics: Arteries; Delayed-Action Preparations; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Menstrual Cycle; Receptors, Androgen; Substrate Specificity; Time | 2003 |
Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxyestrones; Medroxyprogesterone Acetate; Postmenopause; Risk Factors | 2003 |
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
Topics: Androgen Receptor Antagonists; Animals; Benzylidene Compounds; Binding, Competitive; Breast Neoplasms; Cell Division; Cells, Cultured; Chlorocebus aethiops; Epithelial Cells; Estrone; Female; Humans; Mammary Glands, Animal; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Quinolines; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship; Uterus; Vagina | 2003 |
DELAYED IMPLANTATION IN INTACT RATS TREATED WITH MEDROXYPROGESTERONE ACETATE.
Topics: Animals; Embryo Implantation, Delayed; Estrone; Female; Fertilization; Medroxyprogesterone; Medroxyprogesterone Acetate; Pharmacology; Pregnancy; Pregnancy, Animal; Rats; Research | 1964 |
Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
Topics: C-Reactive Protein; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin | 2006 |
Differences in brain volumes among males and female hormone-therapy users and nonusers.
Topics: Aged; Brain; Cognition; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Health Status; Humans; Magnetic Resonance Imaging; Male; Medroxyprogesterone Acetate; Neuropsychological Tests | 2006 |
Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment.
Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Brachial Artery; Contraceptive Agents, Female; Drug Administration Routes; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogens; Estrone; Female; Heart Rate; Humans; Immunoassay; Linear Models; Medroxyprogesterone Acetate; Ultrasonography; Vasodilation | 2011 |